Brazil Halts the Final Stage China Vaccine Trial, Claims Serious Adverse Reaction
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
#WuhanPneumonia #Covid19 #Vaccine
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Source: Channel News Asia #Dec12
Read more
⬇️⬇️⬇️
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Source: Channel News Asia #Dec12
Read more
⬇️⬇️⬇️
#WuhanPneumonia #Covid19 #Vaccine
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Peru has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant #Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health in Lima said on Dec 11, 2020 that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to vaccinate Americans against a supposedly devastating strain of swine flu ground to a halt after about 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru's clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
Source: Channel News Asia #Dec12
https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116
#GuillainBarreSyndrome #Paralysis
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Peru has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant #Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health in Lima said on Dec 11, 2020 that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to vaccinate Americans against a supposedly devastating strain of swine flu ground to a halt after about 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru's clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
Source: Channel News Asia #Dec12
https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116
#GuillainBarreSyndrome #Paralysis
CNA
Peru suspends clinical trials of Chinese COVID-19 vaccine
Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in ...
The Brazilian President Jair Bolsonaro Continued to Criticize China's Vaccine with Low Effectiveness
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
Comparing to 3 other vaccines, SinoVac BioTech from China has the lowest effectiveness (50.38%), while the Moderna vaccine from the US has 94.1% effectiveness. Yet, the Hong Kong government purchases China's vaccine instead of America's.
#COVID19 #Vaccine #SinaVacBioTech #GoHKgraphics
#COVID19 #Vaccine #SinaVacBioTech #GoHKgraphics
Only 45.9% of the interviewees in Hong Kong are willing to be vaccinated, with less than 30% willing to receive Sinovac Biotech vaccine
#COVID19 #vaccine #SinovacBiotech #GoHKgraphics
#COVID19 #vaccine #SinovacBiotech #GoHKgraphics
Brazilian Health Authorities Criticise the Low Transparency of the Chinese Vaccine Emergency Use Standard
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoĂŁoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoĂŁoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
#MadeinChina #WuhanPneumonia
72-year-old man in Hong Kong Suffers hypertension and heart palpitation after China-made #Sinovec Jab
On Feb 27, 2021, a 72-year-old man in Hong Kong was hospitalized after receiving the China-made Sinovec #covid19 vaccinations.
The man suffered hypertension and heart palpitation. It was reported his pulse went up to 100 beats per minute.
He wss among 7,000 people who received Covid-19 vaccinations. The incident happened at a vaccination center operared by #VirtusMedical and the Association of Private Medical Specialists of Hong Kong. The man was sent to Queen Elizabeth Hospital.
According to the government, the China-made Sinovac vaccine is the only vaccine available in Hong Kong at the moment.
Source: Apple Daily; RTHK #Feb27
https://bit.ly/3ku6hCR
https://news.rthk.hk/rthk/en/component/k2/1577893-20210227.htm
#Vaccine #Hypertension
72-year-old man in Hong Kong Suffers hypertension and heart palpitation after China-made #Sinovec Jab
On Feb 27, 2021, a 72-year-old man in Hong Kong was hospitalized after receiving the China-made Sinovec #covid19 vaccinations.
The man suffered hypertension and heart palpitation. It was reported his pulse went up to 100 beats per minute.
He wss among 7,000 people who received Covid-19 vaccinations. The incident happened at a vaccination center operared by #VirtusMedical and the Association of Private Medical Specialists of Hong Kong. The man was sent to Queen Elizabeth Hospital.
According to the government, the China-made Sinovac vaccine is the only vaccine available in Hong Kong at the moment.
Source: Apple Daily; RTHK #Feb27
https://bit.ly/3ku6hCR
https://news.rthk.hk/rthk/en/component/k2/1577893-20210227.htm
#Vaccine #Hypertension
The vaccination project has started the online booking since Feb 23, having 29 community vaccination centres with 2 different types of vaccines for injection.
#COVID19 #Vaccine #SincovacBiotech #BioNTech #GoHKgraphics
#COVID19 #Vaccine #SincovacBiotech #BioNTech #GoHKgraphics
The 1st death case after vaccination in Hong Kong was recorded on 28/2, but the Hospital Authority held a press briefing 3 days after the incident.
#COVID19 #SinovacBiotech #Vaccine #HospitalAuthority #GoHKgraohics
#COVID19 #SinovacBiotech #Vaccine #HospitalAuthority #GoHKgraohics